Adaptyv (YC S21) — We're building fully automated labs for protein engineering
Proteins are the most advanced nanotechnology we know of. At Adaptyv, we’re building a fully automated protein foundry to allow you to synthesize and test any protein you design.
Adaptyv is a Y Combinator company in the Summer 2021 batch. Its directory entry describes it as: We're building fully automated labs for protein engineering. The founders listed are Julian Englert (Founder), Daniel Nakhaee-Zadeh Gutierrez (Founder) (Y Combinator directory entry, August 5, 2021).
Get an email when Adaptyv changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
Proteins are the most advanced nanotechnology we know of. At Adaptyv, we’re building a fully automated protein foundry to allow you to synthesize and test any protein you design.
adaptyvbioorganisation linked from the company's own record
Adaptyv Bio — The Automated Lab for Agentic Biology
Adaptyv generates the data that AI models need to design new proteins — in just 3 weeks. Fully automated lab, clean experimental data, and comprehensive API.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Julian Englert
Founder
Protein Data Dealer @ Adaptyv
Daniel Nakhaee-Zadeh Gutierrez
Founder
I am passionate about engineering biology to positively impact society and the environment. I have been lucky enough to develop my experience over the years in the fields of immunoengineering, synthetic biology and computational biology in some of the best universities in the world (Harvard, University of Leeds, KAIST, EPFL). Now in charge of Operations at Adaptyv.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
One of 60 companies held here in Healthcare › Drug Discovery and Delivery.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Want the whole picture on Adaptyv?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Adaptyv: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Adaptyv covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
9 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
You get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Adaptyv: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
